Amplitude, Inc. logo AMPL - Amplitude, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 8
HOLD 4
SELL 0
STRONG
SELL
0
| PRICE TARGET: $11.17 DETAILS
HIGH: $12.50
LOW: $10.00
MEDIAN: $11.00
CONSENSUS: $11.17
DOWNSIDE: 35.43%

Stock News

Amplitude to Host Third Quarter 2026 Earnings Webcast on November 4, 2026

Amplitude to Host Third Quarter 2026 Earnings Webcast on November 4, 2026

SAN FRANCISCO--(BUSINESS WIRE)---- $AMPL--Amplitude, Inc. (Nasdaq: AMPL), the leading AI analytics platform, today announced that it will release its financial results for the third quarter of 2026 after market close on Wednesday, November 4, 2026. Amplitude will host a video webcast that day at 2:00 PM PT to discuss its financial results and provide its financial outlook for the fourth quarter and full year 2026.The webcast will be available on the Investor Relations section of Amplitude's website at inv.

Oct 14, 2026 04:42 AM • businesswire.com
Head to Head Analysis: Amplitude (NASDAQ:AMPL) and SailPoint (NASDAQ:SAIL)

Head to Head Analysis: Amplitude (NASDAQ:AMPL) and SailPoint (NASDAQ:SAIL)

Amplitude (NASDAQ: AMPL - Get Free Report) and SailPoint (NASDAQ: SAIL - Get Free Report) are both technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, profitability, earnings, analyst recommendations and risk. Insider and Institutional Ownership 73.2% of Amplitude shares are owned

Oct 08, 2026 12:15 AM • defenseworld.net
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis

Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis

SUNNYVALE, Calif., Sept. 30, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell” or the “Company”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that the U.S. Food and Drug Administration (FDA) has cleared new software for the Ceribell System that makes it easier and faster for clinicians to interpret longitudinal brain activity and make appropriate clinical decisions.1 Brain monitoring with electroencephalography (EEG) can generate hours of complex data that can be difficult to interpret in a timely manner.

Sep 30, 2026 03:00 AM • globenewswire.com
Amplitude: The Rebound Rally Is Here, Fueled By Impressive Backlog Growth

Amplitude: The Rebound Rally Is Here, Fueled By Impressive Backlog Growth

Amplitude has rebounded sharply, doubling from YTD lows, driven by strong Q2 results and robust enterprise customer growth. AMPL's AI Analytics platform is capitalizing on accelerated application development cycles, fueling 21% y/y revenue growth and a 35% y/y surge in backlog. Enterprise customers now comprise over 68% of ARR, with the large customer count up 30% y/y and expanded product adoption across the base.

Sep 15, 2026 05:02 AM • seekingalpha.com
Amplitude to Present at Upcoming Investor Conferences

Amplitude to Present at Upcoming Investor Conferences

SAN FRANCISCO--(BUSINESS WIRE)---- $AMPL--Amplitude, Inc. (Nasdaq: AMPL), the leading AI analytics platform, today announced that members of its management team are scheduled to participate in the following investor conferences: Keybanc Technology Leadership Forum Tuesday, August 11, 2:00 p.m. Mountain Time Citi Global TMT Conference Wednesday, September 9, 3:55 p.m. Eastern Time Piper Sandler Growth Frontiers Conference Tuesday, September 15, 3:30 p.m. Central Time The presentations will be webcast live.

Aug 10, 2026 12:30 PM • businesswire.com

Price Targets